I’ll say this: this is the 1st time since COVID1

I’ll say this: this is the 1st time since COVID19 started that I believe Leronlimab could actually be mentioned by the President.

For the record, I have disagreed 100% of the time when investors previously made predictions that President Trump or Dr. Fauci were going to mention Leronlimab. That prediction has been made here so many times since February that I’ve lost count.

But, this time, the circumstances are different. Leronlimab completed a “gold standard” trial via the FDA and showed statistical and clinical improvement. Add the EINDs in there, and there is a real argument that leronlimab could be announced.

The problem is the White House isn’t as predictable as previous WHs. President Trump could make an announcement about the oleander drug or RLFTF, because of the connections those companies have with politicians. To be clear, oleander hasn’t been proven in COVID19 patients at all, and the RLFTF trial is ongoing (with promising EIND results), but having friends in political positions can make a big difference.

One thing we know is this: there aren’t many (or any?) therapeutics as far along as Leronlimab that have proven effective in a legitimate FDA trial.